The follow-up management of non-metastatic renal cell carcinoma: definition of a surveillance protocol.
about
Alpinumisoflavone suppresses tumour growth and metastasis of clear-cell renal cell carcinoma.Challenges and opportunities for converting renal cell carcinoma into a chronic disease with targeted therapies.Fatigue in patients with advanced renal cell carcinoma receiving sunitinib on an intermittent versus continuous dosing schedule in a randomized phase II trial.miRNA profiling in metastatic renal cell carcinoma reveals a tumour-suppressor effect for miR-215The current role of lymph node dissection in the management of renal cell carcinoma.Postoperative surveillance imaging for patients undergoing nephrectomy for renal cell carcinomaLimited use of surveillance imaging following nephrectomy for renal cell carcinoma.From bench to bedside: current and future applications of molecular profiling in renal cell carcinomaAdjuvant and neoadjuvant small-molecule targeted therapy in high-risk renal cell carcinoma.Mutations in the Mitochondrial ND1 Gene Are Associated with Postoperative Prognosis of Localized Renal Cell Carcinoma.Recent advances in the treatment of advanced renal cell carcinoma: towards multidisciplinary personalized care.Post partial nephrectomy surveillance imaging: an evidence-based approach.Hispidulin potentiates the antitumor effect of sunitinib against human renal cell carcinoma in laboratory models.Sphingosine kinase-1 activation causes acquired resistance against Sunitinib in renal cell carcinoma cells.Microvascular density as an independent predictor of clinical outcome in renal cell carcinoma: an automated image analysis study.Profiling microRNA from nephrectomy and biopsy specimens: predictors of progression and survival in clear cell renal cell carcinoma.Features, risk factors and clinical outcome of "very late" recurrences after surgery for localized renal carcinoma: A retrospective evaluation of a cohort with a minimum of 10 years of follow up.Oncological control associated with surgical resection of isolated retroperitoneal lymph node recurrence of renal cell carcinoma.Potentially curable recurrent disease after surgically managed non-metastatic renal cell carcinoma in low-, intermediate- and high-risk patients.Hispidulin suppresses tumor growth and metastasis in renal cell carcinoma by modulating ceramide-sphingosine 1-phosphate rheostat.Venous tumor thrombus consistency is not predictive of survival in patients with renal cell carcinoma: A retrospective study of 147 patients.Robot-assisted partial nephrectomy vs laparoscopic cryoablation for the small renal mass: redefining the minimally invasive 'gold standard'.Development and initial validation of the NCCN/FACT symptom index for advanced kidney cancer.Hispidulin mediates apoptosis in human renal cell carcinoma by inducing ceramide accumulation.
P2860
Q33622716-EA38ED03-559F-4AB1-A191-C1F237048417Q34627828-F1ADCBFD-0504-4620-A8DE-D39652F0243FQ34998569-B3A67CBF-9610-4593-9C6E-646B9771195EQ35623283-0C66E34E-DA2F-40BA-BBD5-D5C0FA25257CQ35687604-FD8FDA5E-717F-412F-A306-5F54D83A2401Q36303564-4EF45D11-2D86-4EA1-8B77-893652593DDDQ36805544-9C519362-C5D1-403A-AB11-6E3A3EB8DD51Q37154789-5562ACC8-1566-48C8-BE05-FC50AB4AD514Q37205794-40911A83-5BBF-4192-AFD8-77F55635BB2CQ37534703-49D591B5-68FA-45E5-8493-B3FEB91320E0Q38012779-DA7C23AC-0345-4FD9-9BFE-8B1193703A7CQ38370142-8C608F25-132A-4FF4-BF70-D8AF07A889C4Q38953038-C0B95F10-DA9E-49A8-A4FD-3C56201617E8Q39105266-C81C9268-332C-4D06-AF1E-17AC619D84DDQ40005099-570F1B1D-67A1-49CC-BDB2-0C8CD4DF94B3Q40232055-4409C7A0-79CD-49A8-B5F6-024911992D45Q40322702-8B42F72E-F09D-4837-884F-72EB9CFF8F92Q40789843-FAB9332E-9F98-4A02-A603-D0E2791DB85BQ40812617-816605F3-3880-42C9-9B99-1442A3889458Q41098262-B117AADF-D25E-4891-817B-E229EA8ED3E8Q41161476-A9E00497-19AD-4090-ACEF-C993DEDED7F0Q43783116-16B35BF0-DA77-4E87-BBCD-550825217B0FQ48187114-4E8B8911-D4BA-4CD9-B310-78EA0C267195Q50098292-D1C1903A-14D9-4E8B-8589-093F05A5660B
P2860
The follow-up management of non-metastatic renal cell carcinoma: definition of a surveillance protocol.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
The follow-up management of no ...... on of a surveillance protocol.
@en
The follow-up management of no ...... on of a surveillance protocol.
@nl
type
label
The follow-up management of no ...... on of a surveillance protocol.
@en
The follow-up management of no ...... on of a surveillance protocol.
@nl
prefLabel
The follow-up management of no ...... on of a surveillance protocol.
@en
The follow-up management of no ...... on of a surveillance protocol.
@nl
P2093
P2860
P1433
P1476
The follow-up management of no ...... on of a surveillance protocol.
@en
P2093
Alberto Cozzoli
Alessandro Antonelli
Claudio Simeone
Danilo Zani
Maria Nicolai
Sergio Cosciani Cunico
Tiziano Zanotelli
P2860
P304
P356
10.1111/J.1464-410X.2006.06616.X
P577
2007-02-01T00:00:00Z